EIP
JAZZ icon

Epoch Investment Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Epoch Investment Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-138,772
Closed -$19.8M – 336
2020
Q3 		$19.8M Buy
138,772
+5,608
+4% +$695K 0.1% 171
2020
Q2 		$14.7M Buy
133,164
+17,928
+16% +$1.98M 0.08% 185
2020
Q1 		$11.5M Buy
115,236
+53,667
+87% +$6.94M 0.07% 193
2019
Q4 		$9.19M Buy
61,569
+36,515
+146% +$4.97M 0.04% 227
2019
Q3 		$3.21M Sell
25,054
-111
-0.4% -$14.9K 0.01% 248
2019
Q2 		$3.59M Sell
25,165
-12,651
-33% -$1.7M 0.02% 245
2019
Q1 		$5.41M Sell
37,816
-8,517
-18% -$1.11M 0.02% 248
2018
Q4 		$5.74M Buy
46,333
+1,190
+3% +$177K 0.03% 236
2018
Q3 		$7.59M Sell
45,143
-119,844
-73% -$20.6M 0.03% 233
2018
Q2 		$28.4M Buy
164,987
+82,315
+100% +$13.5M 0.09% 155
2018
Q1 		$12.5M Buy
82,672
+17,268
+26% +$2.53M 0.04% 214
2017
Q4 		$8.81M Sell
65,404
-14,567
-18% -$2.02M 0.03% 225
2017
Q3 		$11.7M Buy
79,971
+12,385
+18% +$1.87M 0.04% 221
2017
Q2 		$10.5M Buy
67,586
+4,770
+8% +$729K 0.04% 218
2017
Q1 		$9.12M Sell
62,816
-158
-0.3% -$20.6K 0.03% 225
2016
Q4 		$6.87M Buy
62,974
+26,288
+72% +$2.93M 0.03% 194
2016
Q3 		$4.46M Buy
36,686
+31,777
+647% +$4.28M 0.02% 201
2016
Q2 		$694K Buy
+4,909
New +$724K ﹤0.01% 272

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Epoch Investment Partners's JAZZ Position: Q4 2020 in Review

Epoch Investment Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2020, closing a stake of 138,772 shares — an estimated $19.8M sold.

Epoch Investment Partners first reported a position in JAZZ in Q2 2016 and held it in 18 quarters. The position peaked at $28.4M in Q2 2018. 437 funds tracked by Wall St. Rank hold JAZZ as of Q4 2020.

  • Epoch Investment Partners reported no remaining Jazz Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Epoch Investment Partners sold 138,772 Jazz Pharmaceuticals shares in Q4 2020, an estimated $19.8M.
  • Epoch Investment Partners first reported a position in Jazz Pharmaceuticals in Q2 2016 and held it in 18 quarters.
  • Epoch Investment Partners's Jazz Pharmaceuticals position peaked at $28.4M in Q2 2018.
  • 437 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2020.

Based on Epoch Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.